Gitanjali Pai, MD

The CDC altered its mask guidance Tuesday to say that even vaccinated people should wear them indoors in areas with high coronavirus transmission, and that everyone should wear masks indoors in K-12 schools regardless of vaccination status.

The CDC released a draft of revised clinical practice guidelines for HIV PrEP and took feedback from clinicians via two webinars held May 24 and 25.

A new portable, rapid test can detect Neisseria gonorrhoeae in less than 15 minutes — faster than standard-of-care tests that can take hours or days.

ViiV Healthcare said Tuesday that it has initiated a rolling submission of a new drug application for long-acting injectable cabotegravir for HIV PrEP.

Gilead Sciences and Merck announced a partnership to codevelop lenacapavir and islatravir as a long-acting two-drug regimen for patients with HIV.

Results from multiple studies suggest that halving the two-dose series of COVID-19 messenger RNA vaccines may be sufficient to protect people who have recovered from COVID-19.

A 4-month daily regimen of rifapentine and moxifloxacin was noninferior to the standard 6-month regimen for tuberculosis treatment among people with HIV enrolled in a phase 3 clinical trial, researchers reported at CROI.

Timely ART is more common in the United States since the release of HHS treatment guidelines for HIV in 2012, including among groups who have faced racial, ethnic and some geographic disparities in the past, researchers reported.

The NIH said people with HIV should be considered a high-risk group when making decisions about COVID-19 vaccine priority. The recommendation was part of the NIH’s updated interim guidance for COVID-19 and HIV.

Data suggest that in 2018, around 20% of people in the United States had a sexually transmitted infection at some point, with almost half of new infections occurring among people aged between 15 and 24 years, CDC researchers reported.